50
Participants
Start Date
January 1, 2017
Primary Completion Date
April 30, 2017
Study Completion Date
September 10, 2018
Dexmedetomidine
A 2-4 µg/kg dose of the study drug, 2 µg/kg of intranasal dexmedetomidine, will be administered using a LMA MAD Nasal™ -device approximately 20 min prior to planned sedation/anesthesia.
Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital, Turku
University of Turku
OTHER
Turku University Hospital
OTHER_GOV